MW5886A1 - Substituted bridged-diazabicycloalkyl quinolone carboxylic acids - Google Patents

Substituted bridged-diazabicycloalkyl quinolone carboxylic acids

Info

Publication number
MW5886A1
MW5886A1 MW58/86A MW5886A MW5886A1 MW 5886 A1 MW5886 A1 MW 5886A1 MW 58/86 A MW58/86 A MW 58/86A MW 5886 A MW5886 A MW 5886A MW 5886 A1 MW5886 A1 MW 5886A1
Authority
MW
MALAWI
Prior art keywords
carboxylic acids
quinolone carboxylic
substituted bridged
diazabicycloalkyl
alkyl
Prior art date
Application number
MW58/86A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MW5886A1 publication Critical patent/MW5886A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MW58/86A 1985-09-18 1986-08-28 Substituted bridged-diazabicycloalkyl quinolone carboxylic acids MW5886A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77747185A 1985-09-18 1985-09-18

Publications (1)

Publication Number Publication Date
MW5886A1 true MW5886A1 (en) 1987-12-09

Family

ID=25110350

Family Applications (1)

Application Number Title Priority Date Filing Date
MW58/86A MW5886A1 (en) 1985-09-18 1986-08-28 Substituted bridged-diazabicycloalkyl quinolone carboxylic acids

Country Status (42)

Country Link
US (3) US4861779A (zh)
EP (1) EP0215650B1 (zh)
JP (1) JPH0798819B2 (zh)
KR (1) KR870000961B1 (zh)
CN (1) CN1014789B (zh)
AT (1) ATE72245T1 (zh)
AU (1) AU576302B2 (zh)
BG (2) BG49275A3 (zh)
CA (1) CA1340734C (zh)
CY (1) CY1774A (zh)
CZ (1) CZ277825B6 (zh)
DD (1) DD259190A5 (zh)
DE (2) DE19675019I2 (zh)
DK (1) DK171276B1 (zh)
EG (1) EG18184A (zh)
ES (1) ES2001428A6 (zh)
FI (1) FI87565C (zh)
GR (1) GR862363B (zh)
HK (1) HK132795A (zh)
HU (1) HU200462B (zh)
IE (1) IE58966B1 (zh)
IL (1) IL80033A (zh)
IN (1) IN166416B (zh)
LU (1) LU90356I2 (zh)
MA (1) MA20770A1 (zh)
MW (1) MW5886A1 (zh)
MX (1) MX173358B (zh)
MY (1) MY102518A (zh)
NO (1) NO170335C (zh)
NZ (1) NZ217614A (zh)
OA (1) OA08410A (zh)
PH (2) PH24048A (zh)
PL (1) PL149987B1 (zh)
PT (1) PT83388B (zh)
SG (1) SG28094G (zh)
SK (1) SK667886A3 (zh)
SU (1) SU1482531A3 (zh)
UA (1) UA6340A1 (zh)
YU (1) YU45024B (zh)
ZA (1) ZA867063B (zh)
ZM (1) ZM8586A1 (zh)
ZW (1) ZW19386A1 (zh)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (zh) * 1985-09-18 1990-05-05 Pfizer
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
ES2018667B3 (es) * 1986-07-04 1991-05-01 Chemie Linz Gmbh Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
US4965273A (en) * 1986-10-08 1990-10-23 Bristol-Myers Company Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4933335A (en) * 1987-08-07 1990-06-12 Warner-Lambert Company Quinolones as antibacterial agents
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
WO1990002123A1 (en) * 1988-08-23 1990-03-08 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US5147873A (en) * 1988-08-23 1992-09-15 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US4895943A (en) * 1988-10-25 1990-01-23 Pfizer Inc. Preparation of 1,4-diazabicyclo(3.2.2)nonane
US5036153A (en) * 1989-05-11 1991-07-30 Braish Tamim F Preparation of 2,5-diazabicyclo[2.2.1]heptanes and intermediates
US5214051A (en) * 1989-08-01 1993-05-25 Pfizer Inc. Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
US5095121A (en) * 1989-09-25 1992-03-10 Pfizer Inc Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1)heptanes
US5013839A (en) * 1989-09-25 1991-05-07 Pfizer Inc. Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1) heptanes
US5157125A (en) * 1989-09-25 1992-10-20 Pfizer Inc. Optically active 2-alkyl-2,5-diazabicyclo[2.2.1]heptanes
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
CA2105302C (en) * 1991-03-01 1996-11-12 Pfizer Limited 1-azabicyclo¬3.2.2.|nonan-3-amine derivatives
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
GB2291421A (en) * 1994-07-16 1996-01-24 Pfizer A process for preparing a quinoline carboxylic acid
ES2092963B1 (es) * 1995-04-12 1997-12-16 Sint Quimica Sa Procedimiento para la preparacion del acido 1-ciclopropil-6-fluoro-1, 4-dihidro-7-(1s,4s)-5-metil-2,5-diazabiciclo(2.2.1) hept-2-il)-4-oxo-3-quinolincarboxilico y sus sales.
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US6056436A (en) * 1997-02-20 2000-05-02 University Of Maryland Simultaneous measurement of temperature and strain using optical sensors
WO2000066586A1 (en) * 1999-05-04 2000-11-09 Neurosearch A/S Heteroaryl diazabicycloalkanes, their preparation and use
FR2809730B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2809731B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2809732B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
ATE287404T1 (de) * 2001-03-02 2005-02-15 Neurosearch As Diazabicyclo (2.2.1) heptanderivate
EP1551843A1 (en) * 2002-09-10 2005-07-13 Pfizer Products Inc. Diazabicyclic compounds useful in the treatment of cns and other disorders
EP1543000B1 (en) * 2002-09-25 2013-03-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1697378B1 (en) * 2003-12-22 2007-11-21 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
CN103724343A (zh) 2004-03-25 2014-04-16 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途
WO2006001894A1 (en) * 2004-04-22 2006-01-05 Memory Pharmaceutical Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
AU2005243147A1 (en) * 2004-05-07 2005-11-24 Memory Pharmaceuticals Corporation 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE602005019094D1 (de) 2004-12-22 2010-03-11 Memory Pharmaceutical Corp Nikotinische alpha-7-rezeptorliganden gegen erkrankungen des zns
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
US7687517B2 (en) 2006-02-10 2010-03-30 Neurosearch A/S 3,9-Diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN101379063A (zh) 2006-02-10 2009-03-04 神经研究公司 3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途
US7687523B2 (en) 2006-02-10 2010-03-30 Neurosearch A/S 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2009111680A1 (en) * 2008-03-07 2009-09-11 Smithline Beecham Corporation Trpv4 antagonists
CA2755120C (en) * 2009-03-11 2017-05-16 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as gsk-3 inhibitors
WO2012049156A1 (en) 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
EP2934490B1 (de) 2012-12-19 2020-08-12 Bayer Animal Health GmbH Tabletten mit verbesserter akzeptanz und guter lagerstabilität
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
WO2021046305A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
CN115368369A (zh) * 2022-08-16 2022-11-22 浙江国邦药业有限公司 一种甲磺酸达氟沙星脱甲基杂质的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
JPS54112876A (en) * 1978-02-20 1979-09-04 Sumitomo Chem Co Ltd Preparation of 1-substituted-1,4-dihydro-4-oxo-3-quinoline carboxylic acid derivatives
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5823381A (ja) * 1981-08-05 1983-02-12 Nec Corp 磁気バブル検出装置
JPS5823382A (ja) * 1981-08-05 1983-02-12 Nec Corp コンテイギユアス・デイスク・バブル検出・消去器
JPS58204193A (ja) * 1982-01-14 1983-11-28 Kobe Steel Ltd 表面処理鋼板
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
DE3363711D1 (en) * 1982-03-31 1986-07-03 Sterling Drug Inc New quinolone compounds and preparation thereof
JPS58204194A (ja) * 1982-05-21 1983-11-28 Hitachi Ltd 電気ニツケルメツキ方法
JPS58219293A (ja) * 1982-06-15 1983-12-20 Chiyoda Chem Eng & Constr Co Ltd 重質油の水素化分解方法
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
JPS59137481A (ja) * 1983-01-26 1984-08-07 Hokuriku Seiyaku Co Ltd ７−ジアザビシクロアルカン置換−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
EP0191185B1 (en) * 1984-12-14 1990-03-07 Daiichi Seiyaku Co., Ltd. Quinoline-carboxylic acid derivatives
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4684648A (en) * 1985-05-10 1987-08-04 Otsuka Pharmaceutical Company Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof
IN166416B (zh) * 1985-09-18 1990-05-05 Pfizer
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4840956A (en) * 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
DE3721745A1 (de) * 1986-07-04 1988-01-14 Lentia Gmbh Bicyclisch substituierte chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
ES2018667B3 (es) * 1986-07-04 1991-05-01 Chemie Linz Gmbh Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
DE3641312A1 (de) * 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
FI87565C (fi) 1993-01-25
IE862479L (en) 1987-03-18
HU200462B (en) 1990-06-28
YU161786A (en) 1987-10-31
CN1014789B (zh) 1991-11-20
JPH0798819B2 (ja) 1995-10-25
ZA867063B (en) 1988-04-27
LU90356I2 (fr) 1999-04-26
PT83388A (en) 1986-10-01
PL149987B1 (en) 1990-04-30
UA6340A1 (uk) 1994-12-29
BG49275A3 (en) 1991-09-16
CA1340734C (en) 1999-09-14
EP0215650A3 (en) 1987-12-02
US4861779A (en) 1989-08-29
DK171276B1 (da) 1996-08-19
NO170335C (no) 1992-10-07
MY102518A (en) 1992-07-31
SG28094G (en) 1994-10-28
FI863756A (fi) 1987-03-19
NO170335B (no) 1992-06-29
YU45024B (en) 1991-06-30
PH24048A (en) 1990-03-05
IL80033A (en) 1992-05-25
MA20770A1 (fr) 1987-04-01
ES2001428A6 (es) 1988-05-16
US4775668A (en) 1988-10-04
KR870003106A (ko) 1987-04-15
MX173358B (es) 1994-02-23
BG61091B2 (bg) 1996-10-31
ZM8586A1 (en) 1987-03-27
CY1774A (en) 1995-10-20
ATE72245T1 (de) 1992-02-15
FI863756A0 (fi) 1986-09-17
NZ217614A (en) 1989-11-28
DK445886A (da) 1987-05-27
EP0215650A2 (en) 1987-03-25
HUT43070A (en) 1987-09-28
IL80033A0 (en) 1986-12-31
CZ277825B6 (en) 1993-06-16
PH25338A (en) 1991-04-30
KR870000961B1 (ko) 1987-05-14
ZW19386A1 (en) 1986-12-10
JPS62103083A (ja) 1987-05-13
IE58966B1 (en) 1993-12-01
AU6276886A (en) 1987-03-19
EP0215650B1 (en) 1992-01-29
HK132795A (en) 1995-09-01
MX3751A (es) 1993-09-01
SU1482531A3 (ru) 1989-05-23
PL261410A1 (en) 1987-11-16
IN166416B (zh) 1990-05-05
DE3683711D1 (de) 1992-03-12
AU576302B2 (en) 1988-08-18
NO863718L (no) 1987-03-19
CN86106385A (zh) 1987-06-03
DE19675019I2 (de) 2004-01-29
GR862363B (en) 1987-01-19
OA08410A (fr) 1988-06-30
DD259190A5 (de) 1988-08-17
PT83388B (pt) 1989-05-12
FI87565B (fi) 1992-10-15
NO863718D0 (no) 1986-09-17
US5091383A (en) 1992-02-25
CZ667886A3 (en) 1993-02-17
DK445886D0 (da) 1986-09-17
SK278605B6 (en) 1997-11-05
EG18184A (en) 1992-12-30
SK667886A3 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
ZA867063B (en) Substituted bridged-diazabicycloalkyl quinolone carboxylic acids
DE3876712T2 (de) Antianaerobe naphthyridinverbindungen.
DE68913099T2 (de) Amino-substituierte verbrückte azabicyclische Chinoloncarbonsäure und Ester.